Kadmon Announces Abstract Accepted for Presentation at the Society for Immunotherapy of Cancer’s 35th Anniversary Annual Meeting
NEW YORK, NY / ACCESSWIRE / October 20, 2020 / Kadmon Holdings, Inc. (NYSE:KDMN) announced today it will present preclinical...